Venture capital for
Life Sciences
We are a life sciences investment firm partnering with industry leaders to build game-changing medicines and technologies with a focus on novel therapeutics for unmet medical needs.
Founded in 2011,
venBio’s venture funds comprise nearly
in committed capital
$
1.1
billion
approved drugs
1
FDA
diseases
FOR
1
Companies
that Matter
We are mindful of potential acquisition partners from the outset, and we ensure that our companies are best positioned to meet their requirements. This includes intellectual property (IP), chemistry, manufacturing (CMC), and the details of clinical trials, including indication, trial design, endpoints, powering, and regulatory considerations. Our team’s expertise and involvement helps companies make a bigger impact, and this leads to impactful and lasting relationships with the leaders that we work with.
Our mission
We seek out teams who are developing treatments that will have a meaningful impact on patient care. Our mission is to put our companies in the best possible position to succeed, by helping teams think through the best development plan to bring these therapies to patients.
